Navigation Links
Aricept Cleared for Advanced Alzheimer's Treatment

Aricept becomes the first drug to be cleared for treatment of all stages of Alzheimer's, the FDA declared on Oct 13. It had been previously approved// for treating the initial stages of the disease. Eisai shares rose on the announcement upto 6,180 yen on the Tokyo Stock Exchange on Monday morning.

Alzheimer's is a progressive disease with no known cure, which affects brain functions of memory and thinking, leading to the patient's death after much mental deterioration. Doctors are already prescribing Aricept for the advanced stages, so the approval only gives an official status to the drug use.

The other drug being used in the US for treating the advanced stages of the disease is Namenda (Forest Laboratories).

Pfizer and Eisai entered an agreement in 1994 for promoting Aricept, which was discovered and developed by Eisai. This approval is likely to see consolidation of Pfizer's share of the Alzheimer's market. Sales of the drug have been forecast at $1.9 billion through March 2007

'"/>




Page: 1

Related medicine news :

1. Is Aricept, the Alzheimer’s Drug Safe to Use against Vascular Dementia
2. ‘Aricept’ drug gives an Alzheimer’s patient reason to smle
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. The Decks Cleared For HRT - Safe for Menopause Symptoms
5. Doctor Cleared Of Charges of Killing a baby
6. Orissa Villagers Jubilant as Girl Cleared Class X Examination
7. Patent for Seminal RNAi innovation Cleared in Australia
8. Risperdal Cleared By FDA To Treat Autistic Children
9. A Woman Dies Due to Breast Cancer After Being Cleared in the Breast Scan
10. Drug For Iron Overload Cleared
11. Advanced STD programs required
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss ... WE TV’s “Mama June: From Not to Hot,” which will begin airing on February ... Shannon, known to millions from the 2012 reality television series, “Here Comes Honey Boo ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... host a diverse symposium on “Doping in Sport: How the Culture Might ... Richter & Hampton LLP. The symposium will be held at Pepperdine University in ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: